Evidence map›Paper›PMID 32054997›Full record

ArticleBone marrow transplantation2020

HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation.

B Grønvold, M M Ali, M Remberger, J Mattsson, T Egeland, K U Lundin, A E Myhre, I W Abrahamsen, D Heldal, I Dybedal and 3 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

B GrønvoldDepartment of Haematology, Oslo University Hospital, Oslo, Norway. bjoegr@ous-hf.no.
M M AliDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
M RembergerDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
J MattssonGloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
T EgelandInstitute of Immunology, Oslo University Hospital, Oslo, Norway.
K U LundinInstitute of Immunology, Oslo University Hospital, Oslo, Norway.
A E MyhreDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
I W AbrahamsenDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
D HeldalDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
I DybedalDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
G E TjønnfjordDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
Y Fløisand *Department of Haematology, Oslo University Hospital, Oslo, Norway.
T Gedde-Dahl *Department of Haematology, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHistocompatibility TestingHLA-DP beta-ChainsHumansNeoplasm Recurrence, LocalT-LymphocytesUnrelated DonorsHLA-DPB1 antigenHLA-DP beta-Chains

Identifiers

PMID32054997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.